Literature DB >> 32247582

TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response.

Daniela Stöhr1, Albert Jeltsch2, Markus Rehm3.   

Abstract

The cytokine tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the large TNF superfamily that can trigger apoptosis in transformed or infected cells by binding and activating two receptors, TRAIL receptor 1 (TRAILR1) and TRAIL receptor 2 (TRAILR2). Compared to other death ligands of the same family, TRAIL induces apoptosis preferentially in malignant cells while sparing normal tissue and has therefore been extensively investigated for its suitability as an anti-cancer agent. Recently, it was noticed that TRAIL receptor signaling is also linked to endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). The role of TRAIL receptors in regulating cellular apoptosis susceptibility therefore is broader than previously thought. Here, we provide an overview of TRAIL-induced signaling, covering the core signal transduction during extrinsic apoptosis as well as its link to alternative outcomes, such as necroptosis or NF-κB activation. We discuss how environmental factors, transcriptional regulators, and genetic or epigenetic alterations regulate TRAIL receptors and thus alter cellular TRAIL susceptibility. Finally, we provide insight into the role of TRAIL receptors in signaling scenarios that engage the unfolded protein response and discuss how these findings might be translated into new combination therapies for cancer treatment.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; ER stress; Programmed cell death; TRAIL; TRAIL receptors; Unfolded protein response

Year:  2020        PMID: 32247582     DOI: 10.1016/bs.ircmb.2020.02.002

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  6 in total

Review 1.  Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer.

Authors:  Marilyne Labrie; Joan S Brugge; Gordon B Mills; Ioannis K Zervantonakis
Journal:  Nat Rev Cancer       Date:  2022-03-09       Impact factor: 69.800

2.  Functional Expression, Purification and Identification of Interaction Partners of PACRG.

Authors:  Tiankai Liu; Haizhou Zhao; Shaofen Jian; Shu Gong; Sainan Li; Yanhong Ma; Jun Chen; Wenhua Liu
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

3.  ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells.

Authors:  Cathrin Hagenlocher; Robin Siebert; Bruno Taschke; Senait Wieske; Angelika Hausser; Markus Rehm
Journal:  Cell Death Discov       Date:  2022-01-24

Review 4.  Endoplasmic Reticulum Stress in Diabetic Nephrology: Regulation, Pathological Role, and Therapeutic Potential.

Authors:  Lihua Ni; Cheng Yuan; Xiaoyan Wu
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

5.  Two-level modeling approach to identify the regulatory dynamics capturing drug response heterogeneity in single-cells.

Authors:  Madalena Chaves; Luis C Gomes-Pereira; Jérémie Roux
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

Review 6.  NF-κB and its crosstalk with endoplasmic reticulum stress in atherosclerosis.

Authors:  Wenjing Li; Kehan Jin; Jichang Luo; Wenlong Xu; Yujie Wu; Jia Zhou; Yilin Wang; Ran Xu; Liqun Jiao; Tao Wang; Ge Yang
Journal:  Front Cardiovasc Med       Date:  2022-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.